Berahyaluronidase Alfa
Records for this ingredient, by country (identity only).
ATC — · 2 markets · 11 records
JP 9 records · 5 shown of 6
Combination products containing this ingredient
- 15 mL per mL / per unit basis not statedinjection CombinationBerahyaluronidase Alfa 15 mL + Daratumumab 15 mLダラキューロ配合皮下注
- 10 mL per mL / per unit basis not statedinjection CombinationAmivantamab 10 mL + Berahyaluronidase Alfa 10 mLリブロファズ配合皮下注
- 5.6 mL per mL / per unit basis not statedinjection CombinationBerahyaluronidase Alfa 5.6 mL + Efgartigimod Alfa 5.6 mLヒフデュラ配合皮下注
- 5 mL per mL / per unit basis not statedinjection CombinationBerahyaluronidase Alfa 5 mL + Efgartigimod Alfa 5 mLヒフデュラ配合皮下注シリンジ
- 15 mL per mL / per unit basis not statedinjection CombinationBerahyaluronidase Alfa 15 mL + Pertuzumab 15 mL + Trastuzumab 15 mLフェスゴ配合皮下注 IN
Other strengths: 1 · 1 dosage forms Otras concentraciones: 1 · 1 formas farmacéuticas 其余规格 1 个 · 涉及 1 种剂型 其餘規格 1 個 · 涉及 1 種劑型
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ハイキュービア10%皮下注セット20g/200mL ×3
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 2 records · 1 shown of 1
Combination products containing this ingredient
- 2,000 unit per mL / per unit basis not statedinjection CombinationBerahyaluronidase Alfa 2,000 unit + Pembrolizumab 165 mgKEYTRUDA QLEX
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.